Navigation Links
Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs
Date:6/14/2011

nded protocol is now being finalized by the investigators, and may be modified again in the future although we do not anticipate any significant additional delays.

While the central aim of the study is to determine efficacy of our MDT compounds in certain patients in certain cancers, and we are involved in reviewing the study's design, the study itself is being conducted and controlled by the hospital investigators. IRB review is expected to be completed between June and July 2011 and the Company expects the I-IND to be submitted shortly thereafter.

About Viral Genetics, Inc.

San Marino, California-based Viral Genetics discovers drug therapies from two platform technologies based on over 60 patents: Metabolic Disruption (MDT) and Targeted Peptides (TPT). Founded in 1994, the biotech company is researching treatments for HIV/AIDS, Lyme Disease, Strep, Staph and drug resistant cancer. A majority-owned subsidiary, VG Energy (www.vgenergy.net), is dedicated to exploring biofuel and agricultural applications for the MDT platform. For more information, visit www.viralgenetics.com.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Viral Genetics, Inc. from time to time in its periodic reports, including statements about its VG Energy, Inc. subsidiary. None of Viral Genetics' drug compounds are approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world, nor are any non-pharmaceutical products of VG Energy, Inc. commercialized. While Viral Genetics believes that the forward-looking statements and underlying assumptions reasonable, any of the assumptions could be inaccurate,
'/>"/>

SOURCE Viral Genetics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
3. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
4. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
5. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
6. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
7. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
8. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
9. BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
10. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
11. Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015 NxStage Medical, Inc. ... products, today announced that Jeffrey H. Burbank , Chief ... Care Conference in Boston, MA on ... A webcast of the event will be made available ... About NxStage NxStage Medical, Inc. ...
(Date:4/27/2015)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... for human disease, will release its first quarter 2015 ... financial markets close.  Lexicon management will hold a conference ... financial results for the first quarter 2015 at 5:00 ... The dial-in number for the conference call is 888-645-5785 ...
(Date:4/27/2015)... 27, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that it ... Food and Drug Administration ("FDA") verifying that the Company ... the warning letter it received from the FDA in ... re-inspection in March 2015 by the FDA at CryoLife,s ...
Breaking Medicine Technology:NxStage to Present at the 40th Annual Deutsche Bank Securities Health Care Conference 2Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2CryoLife Announces Resolution of FDA Warning Letter 2
... the new screening guidelines announced by the National,Comprehensive Cancer ... will encourage those at high risk for lung cancer ... LCA President Laurie Fenton Ambrose said that lung ... all the other major cancers combined,until more at risk ...
... ILE ) announced today the completion of ... Study IT-A-008 investigating the Isolagen,Therapy(TM) for the treatment ... be administered at seven clinical sites across the ... Therapy could hold great promise for the,treatment of ...
Cached Medicine Technology:Lung Cancer Alliance Commends NCCN on Screening Guidelines 2Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study 2Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study 3
(Date:4/28/2015)... 2015 SeniorCare.com has published the ... reality problem Americans have regarding aging and long-term care ... care services as they age, 63% of Americans do ... In the report, Carol Marak of SeniorCare.com interviewed 44 ... Health Care Association and The Scan Foundation. The experts ...
(Date:4/28/2015)... FL (PRWEB) April 28, 2015 ... organization which provides vascular, electrocardiogram, echocardiogram, and NCV ... non-invasive vascular testing to help podiatrists diagnose peripheral ... challenging to diagnose PAD without the aid of ... Chief Medical Officer at Wimbledon Health Partners. ...
(Date:4/28/2015)... MO (PRWEB) April 28, 2015 The ... 2015 from 5:00 to 8:00 pm at the Sheraton Colonial ... than 50 hospitals, clinics and groups with career opportunities will ... represented. Attendees will enjoy free hors d’oeuvres and raffle prize ... PracticeMatch says “Boston is an ideal location to hold ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 The Awareness Counselor ... the common topic of judging. According to Awareness Counselor, there ... people, when directed outward, and to an individual who self-judges. ... new clients as a class or one one one talk. ... founder of Awareness Counselor, is that every being on earth ...
(Date:4/28/2015)... Aliso Viejo, CA (PRWEB) April 28, 2015 ... created for use in Final Cut Pro X ... attention to specific areas on-screen with classic buttons, animated ... Annotate is the perfect compliment to vlogs, video series, ... Cut Pro X 10.2 or newer. ProTube Annotate ...
Breaking Medicine News(10 mins):Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 3Health News:FCPX plugin developer Pixel Film Studios releases Protube Annotate plugin for Final Cut Pro X. 2
... A Dartmouth-led study of young U.S. teens showed that ... items featuring an alcohol brand, and those who do ... drinking from susceptibility, to beginning drinking, to binge drinking, ... Archives of Pediatrics & Adolescent Medicine . , ...
... study finds , , TUESDAY, March 3 (HealthDay News) -- The ... the worse his sex life, a new study finds. , ... bypass surgery can help reverse those ills. , "Previous studies ... and can be associated with infertility, but we wanted to ...
... long-term investment and social responsibility in industry categoryMADISON, N.J., ... DGX ), the world,s leading provider of diagnostic testing, ... magazine,s list of the World,s Most Admired Companies. Quest ... "Pharmacy and Other Services." The 2009 ranking is the ...
... long-term care insurance. , ... Newark, NJ (PRWEB) March 3, 2009 -- ... you off, Prudential has a way out the maze. Prudential ... confuse the decision-making process., , , , ,Although its design is simpler, ...
... of the World,s Most Admired CompaniesEL SEGUNDO, Calif., March ... care services, today accepted the honor by FORTUNE ... facilities in the country. DaVita(R) ranked #1 in the ... Investment and Quality of Products and Services. Overall, the ...
... LITTLE FALLS, N.J., March 3 Cantel Medical Corp. (NYSE: ... discuss the Company,s results for its second quarter ended January ... Participating in the call will be Charles M. Diker, ... President and CFO; and Roy K. Malkin, President of Minntech ...
Cached Medicine News:Health News:Owning alcohol-branded merchandise associated with teen drinking behaviors 2Health News:Men's Sex Lives May Suffer as Waistlines Expand 2Health News:Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List 2Health News:Prudential Long-Term Care Product Simplifies Decisions 2Health News:Prudential Long-Term Care Product Simplifies Decisions 3Health News:FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality 2Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2009 2
... is a fully automated, benchtop coagulation ... and immunological assays in true random ... of sample management offers high throughput ... without the need to interrupt current ...
The CA-50 is a compact semi-automated coagulation analyzerproviding 4-parameter random access....
... The ACL 100 is ... volume workloads, or as a ... also runs clotting assays, such ... Plus, it's backed by superior ...
... StatSite MHgb test system is ... dedicated hemoglobin test system designed ... public health clinics, blood centers ... portable system is designed for ...
Medicine Products: